Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 21 matching records.
21 results — page 1 of 1
- Level CCase Report / SeriesPubMed
Case Report: Intravenous transplantation of autologous adipose tissue-derived mesenchymal stem cells attenuated atopic dermatitis.
Case Report / Series on Systemic / IV, published in Front Med (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
Front Med (Lausanne) - Level AMeta-analysisPubMed
The Potential Role of Mesenchymal Stem Cell Therapy for Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis of Human Clinical Trials.
Meta-analysis with a reported sample of 236, published in Stem Cells Dev (2026) — summary generated from the PubMed abstract.
- 2026
- n = 236
Stem Cells Dev - Level BClinical TrialEurope PMC
Therapeutic Potential and Mechanisms of Mesenchymal Stem Cell and Mesenchymal Stem Cell-Derived Extracellular Vesicles in Atopic Dermatitis
Clinical Trial on Chronic Inflammation, Immune Modulation, published in J Inflamm Res (2024) — summary generated from the PubMed abstract.
- 2024
J Inflamm Res6 citations - Level DAnimal StudyPubMed
Canine Mesenchymal-Stem-Cell-Derived Extracellular Vesicles Attenuate Atopic Dermatitis.
Animal Study on Chronic Inflammation, Immune Modulation, published in Animals (Basel) (2023) — summary generated from the PubMed abstract.
- 2023
Animals (Basel)12 citations - Level DLaboratory StudyPubMed
Immunomodulatory effects of canine mesenchymal stem cells in an experimental atopic dermatitis model.
Laboratory Study on Immune Modulation, published in Front Vet Sci (2023) — summary generated from the PubMed abstract.
- 2023
Front Vet Sci - Level DAnimal StudyPubMed
Mesenchymal Stem Cells and Extracellular Vesicles Derived from Canine Adipose Tissue Ameliorates Inflammation, Skin Barrier Function and Pruritus by Reducing JAK/STAT Signaling in Atopic Dermatitis.
Animal Study on Chronic Inflammation, Immune Modulation, published in Int J Mol Sci (2022) — summary generated from the PubMed abstract.
- 2022
Int J Mol Sci - Level DAnimal StudyEurope PMC
Extracellular vesicles from IFN-γ-primed mesenchymal stem cells repress atopic dermatitis in mice
Animal Study on Chronic Inflammation, published in J Nanobiotechnology (2022) — summary generated from the PubMed abstract.
- 2022
J Nanobiotechnology26 citations - Level DNarrative ReviewPubMed
Recent advance in mesenchymal stem cells therapy for atopic dermatitis.
Narrative Review on Immune Modulation, published in J Cell Biochem (2022) — summary generated from the PubMed abstract.
- 2022
J Cell Biochem - Level DAnimal StudyEurope PMC
Therapeutic Effects of Tonsil-derived Mesenchymal Stem Cells in an Atopic Dermatitis Mouse Model
Animal Study on Chronic Inflammation, Immune Modulation, published in In Vivo (2021) — summary generated from the PubMed abstract.
- 2021
In Vivo12 citations - Level CCase Report / SeriesPubMed
Exosomes derived from human adipose tissue-derived mesenchymal stem cells for the treatment of dupilumab-related facial redness in patients with atopic dermatitis: A report of two cases.
Case Report / Series on Face & Skin, published in J Cosmet Dermatol (2021) — summary generated from the PubMed abstract.
- 2021
J Cosmet Dermatol - Level DNarrative ReviewEurope PMC
Mesenchymal stem/stromal cell therapy in atopic dermatitis and chronic urticaria: immunological and clinical viewpoints
Narrative Review on Systemic / IV, published in Stem Cell Res Ther (2021) — summary generated from the PubMed abstract.
- 2021
Stem Cell Res Ther4 citations - Level BRandomized Controlled TrialPubMed
A double-blinded placebo-controlled evaluation of adipose-derived mesenchymal stem cells in treatment of canine atopic dermatitis.
Randomized Controlled Trial, published in Vet Res Commun (2021) — summary generated from the PubMed abstract.
- 2021
Vet Res Commun7 citations - Level DAnimal StudyPubMed
Exosomes from Human Adipose Tissue-Derived Mesenchymal Stem Cells Promote Epidermal Barrier Repair by Inducing de Novo Synthesis of Ceramides in Atopic Dermatitis.
Animal Study on Chronic Inflammation, published in Cells (2020) — summary generated from the PubMed abstract.
- 2020
Cells - Level DNarrative ReviewPubMed
Mesenchymal Stem Cells and Atopic Dermatitis: A Review.
Narrative Review on Chronic Wound, Immune Modulation, published in Front Cell Dev Biol (2020) — summary generated from the PubMed abstract.
- 2020
Front Cell Dev Biol33 citations - Level DAnimal StudyEurope PMC
Umbilical cord-derived mesenchymal stem cell extracts ameliorate atopic dermatitis in mice by reducing the T cell responses
Animal Study on Chronic Inflammation, Immune Modulation, published in Sci Rep (2019) — summary generated from the PubMed abstract.
- 2019
Sci Rep34 citations - Level DLaboratory StudyPubMed
Exosomes derived from human adipose tissue-derived mesenchymal stem cells alleviate atopic dermatitis.
Laboratory Study on Systemic / IV, published in Stem Cell Res Ther (2018) — summary generated from the PubMed abstract.
- 2018
Stem Cell Res Ther - Level BClinical TrialPubMed
Allogeneic adipose-derived mesenchymal stem cell therapy in dogs with refractory atopic dermatitis: clinical efficacy and safety.
Clinical Trial on Immune Modulation, Autoimmune Research, published in Vet Rec (2018) — summary generated from the PubMed abstract.
- 2018
Vet Rec - Level DAnimal StudyPubMed
Human Adipose Tissue-Derived Mesenchymal Stem Cells Attenuate Atopic Dermatitis by Regulating the Expression of MIP-2, miR-122a-SOCS1 Axis, and Th1/Th2 Responses.
Animal Study, published in Front Pharmacol (2018) — summary generated from the PubMed abstract.
- 2018
Front Pharmacol36 citations - Level DAnimal StudyPubMed
Human adipose tissue-derived mesenchymal stem cells alleviate atopic dermatitis via regulation of B lymphocyte maturation.
Animal Study on Immune Modulation, published in Oncotarget (2017) — summary generated from the PubMed abstract.
- 2017
Oncotarget62 citations - Level DLaboratory StudyPubMed
[Mesenchymal stem cells influence on leukocytes allergen-specific reactions in case of atopic hypersencitivity].
Laboratory Study with a reported sample of 16 on Immune Modulation, published in Tsitologiia (2015) — summary generated from the PubMed abstract.
- 2015
- n = 16
Tsitologiia - Level BClinical TrialPubMed
Evaluation of the potential use of adipose-derived mesenchymal stromal cells in the treatment of canine atopic dermatitis: a pilot study.
Clinical Trial on Systemic / IV, published in Vet Ther (2010) — summary generated from the PubMed abstract.
- 2010
Vet Ther26 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406